Do you need bisphosphonate therapy after a DEXA scan?

DEXA assesses bone mineral density at selected sites, commonly the hip and spine. The report may describe bone density as within the expected range, lower than expected, or in an osteoporosis range. That description is one part of the decision. A previous fragility fracture, age, falls, kidney function, other medical conditions and medicines that affect bone can change the recommendation. The scan also has limitations, so the number should be interpreted with the clinical history rather than treated as a diagnosis in isolation. Bisphosphonate therapy slows bone breakdown and is prescribed when its likely benefit fits the person’s risk and health profile.

Book a review to go through the actual report and ask what it means for your fracture risk. Share your medicine list, previous fractures, dental concerns, kidney history, falls and dietary pattern. Do not start, stop or alter bone medicine without medical advice. Your plan may include strength and balance work, fall-prevention changes, adequate calcium and vitamin D intake when appropriate, and repeat monitoring. If treatment is offered, ask how it is taken, how long the initial plan lasts, and which symptoms should be reported.

Seek prompt review after a new fracture, sudden severe back or hip pain, or a fall that causes difficulty standing or walking. If you take a bisphosphonate, report new thigh or groin pain, persistent jaw symptoms, trouble swallowing, or marked muscle and bone pain. Emergency care is needed for a suspected hip fracture, inability to bear weight, or breathing difficulty after a serious fall.

Ask which part of the DEXA report matters most, whether a fracture-risk assessment is needed, how kidney health or dental treatment affects options, and how progress will be monitored.